Symphonix Devices, Inc. Appoints New Chairman and New Member to Its Board of Directors

SAN JOSE, Calif. - Symphonix Devices, Inc. (NASDAQ: SMPX)
recently announced two changes to its governing board at the company's
annual meeting. President and Chief Executive Officer (CEO) Kirk Davis has
been appointed Chairman of the Board of Directors and George G. Montgomery has been elected as a member of the Board.

''Kirk's appointment to the position of Chairman is a logical evolution,
given his current role as CEO,'' said B.J. Cassin, a Symphonix board member. ''The consolidation of these two leadership positions will streamline the decision-making process, giving Kirk the ability to work quickly and decisively to guide us through the approaching commercialization of the
Vibrant® Soundbridge™ and a fast-paced sales ramp-up.' Symphonix has
been working constructively with the Food and Drug Administration (FDA) on
its pre-market approval (PMA) application to obtain marketing authorization for its proprietary, semi-implantable hearing device.

Mr. Davis has held the position of president and CEO of Symphonix since
August of 1999. Prior to joining Symphonix, he worked for 12 years with
Abbott Laboratories, most recently as vice president and general manager of
Abbott's critical care products business. He served previously as general manager of Abbott UK and as vice president and regional director for
Abbott/Europe. Mr. Davis has a BS degree from Stanford University and an
MBA degree from the J.L. Kellogg Graduate School of Management at
Northwestern University.

Of Mr. Montgomery's election to the Board, Mr. Davis said, 'George brings
to the Board his extensive experience in healthcare finance and investment,
as well as strong business relationships built throughout his career. These assets will be valuable to Symphonix as we begin to consider additional strategic alliances that fit into our long range plans.'

Mr. Montgomery is currently the chief financial officer at Pinpoint
Therapeutics, a private medical device company, where he has served since
July of 1999. Prior to working at Pinpoint, he was a managing director of
healthcare investment banking at SG Cowen, and previous to that was a vice
president at CS First Boston. Mr. Montgomery holds a BA degree from Yale
University and an MBA degree from the Wharton School at the University of
Pennsylvania.

'Symphonix is entering into a very exciting time in its history right now,'
said Mr. Montgomery. 'I am excited to have the opportunity to work with the
Board and help shape the company's future.'

About Symphonix

Founded in 1994, Symphonix Devices, Inc. is a hearing management company dedicated to developing a family of products to improve communication ability and quality of life for the millions of hearing-impaired
individuals who cannot benefit from current hearing technology. Symphonix'
Vibrant Soundbridge is a surgical implant designed to work with the natural structures of the middle ear to enhance hearing and communication ability for people with hearing impairment. The device can be implanted during a short, outpatient surgical procedure. Worldwide, more than 350 patients have been implanted with Vibrant Soundbridges. More information about Symphonix can be found at https://www.symphonix.com.

Except for historical information, statements made in this press release
are 'forward looking statements' and are subject to a number of
uncertainties that could cause actual results to differ materially from the
statements made. Such risks and uncertainties include, but are not limited
to, the risks that regulatory approvals will not be obtained in a timely
manner, or at all, and that the Company's products will not achieve
widespread market acceptance. For further information, refer to the risk
factors described in the Company's Form 10Q for the quarter ended March 31,
2000.
__________

Vibrant is a registered trademark of Symphonix Devices, Inc. Soundbridge is
a trademark of Symphonix Devices, Inc.